Kengo Himei

Okayama Red Cross General Hospital

Papers

2

Total Citations

58

H-Index

2

About

Kengo Himei is a leading radiation oncologist whose research focuses on reirradiation strategies for recurrent head and neck cancers, with a particular emphasis on advanced stereotactic techniques. His major contributions include pioneering the use of CyberKnife robotic image-guided stereotactic radiotherapy for previously irradiated patients, demonstrating its efficacy while carefully characterizing treatment-limiting toxicities such as mucosal ulceration. In a landmark multi-institutional study involving 107 patients, Himei established critical prognostic factors for this challenging population. He further advanced the field by conducting the first matched-cohort analysis comparing charged particle radiotherapy with CyberKnife stereotactic body radiotherapy, providing essential comparative effectiveness data for clinicians selecting reirradiation modalities. His work has garnered significant attention, with his foundational 2016 paper accumulating 47 citations, reflecting its importance in guiding clinical decision-making for patients with limited treatment options. By systematically addressing the risks and outcomes of reirradiation, Himei has helped expand therapeutic possibilities for recurrent head and neck cancer, offering hope where conventional approaches have been exhausted.

Research Focus

Key Achievements

2
H-Index
2
Papers
58
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer
47 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Okayama Red Cross General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago